In accordance with FAR Subpart 13.106-1(b) the Centers for Disease Control and Prevention (CDC) intends to issue a sole-source purchase order to Bee Robotics LTDS in Gwynedd United Kingdom. CDC Human Papillomavirus program is routinely pursuing HPV genotyping assays with the Linear Array HPV Genotyping Kit (Roche Applied Science). This assay has been proven very reliable and sensitive and has become a core of many epidemiological population studies. The current manual process is quite labor intensive and has met the maximum capacity of the available recourses. The demand for automation and increased throughput is eminent. The BeeBlot instrument from Bee Robotics Ltd. automates temperature controlled washing and hybridization steps of strip-based assays like the HPV Genotyping kit. It allows simultaneous processing of 48 samples with minimal labor input and a greater degree of standardization and reproducibility. The BeeBlot meets all technical specifications to directly adapt Roche's HVP genotyping assay and has in fact successfully been evaluated in our laboratory. Interested parties who feel that they possess the capabilities to provide the services described above should submit a capability statement demonstrating their abilities to provide the services. The information recveived in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Please send your documentation to Rafael Aviles at the office identified above, by fax (770) 488-2668 or email to [email protected]. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract based upon responses to this notice is solely within discretion of the government.

Bid Protests Not Available